Skip to Content Facebook Feature Image

Bruker Expands Infection Detection Portfolio with Acquisition of Metagenomic mNGS DISQVER® Platform for Pathogenic Microorganisms in Blood

Business

Bruker Expands Infection Detection Portfolio with Acquisition of Metagenomic mNGS DISQVER® Platform for Pathogenic Microorganisms in Blood
Business

Business

Bruker Expands Infection Detection Portfolio with Acquisition of Metagenomic mNGS DISQVER® Platform for Pathogenic Microorganisms in Blood

2026-07-15 19:00 Last Updated At:19:10

BREMEN, Germany--(BUSINESS WIRE)--Jul 15, 2026--

Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of the DISQVER ® clinical metagenomics platform from Noscendo GmbH.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260715763519/en/

DISQVER ® enables metagenomic next-generation sequencing (mNGS) analysis of microbes directly from blood samples, further expanding Bruker's NGS-based infection detection capabilities. Without any need for prior cultivation, DISQVER analyzes whole genome sequencing (WGS) data and applies advanced, proprietary bioinformatics to search for more than 11,000 different microbes and parasites. The mNGS analysis can be done directly from cell-free DNA samples from blood, in less than 24 hours after sample receipt. This advanced mNGS clinical research approach can be valuable for bloodstream infections, sepsis, endocarditis, and other severe infectious diseases.

Following the acquisition, DISQVER ® remains available for research use only, while Bruker is progressing its registration for diagnostic purposes. Financial details of the transaction were not disclosed, and DISQVER ® is not expected to be material to Bruker’s FY26 financial results.

Dr. Wolfgang Pusch, President of Bruker Microbiology & Infection Diagnostics, commented: “ The acquisition of the DISQVER®proprietary software and workflow platform is the latest step in our evolution as an innovative microbiology and molecular diagnostics business. We have expanded into rapid antimicrobial susceptibility testing (AST), hospital hygiene testing, sample-to-answer molecular diagnostics with the ELITech Genius platform, and most recently into NGS for infectious disease testing. DISQVER®adds additional NGS applications to our portfolio for metagenomics, and enhances our support for earlier decision-making in sepsis, bloodstream infections, and severe infections. "

About Bruker Corporation – Leader of the Post-Genomic Era (Nasdaq: BRKR)

Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in post-genomic life science molecular and cell biology research, in applied and biopharma applications, in microscopy and nanoanalysis, as well as in industrial and cleantech research, and next-gen semiconductor metrology in support of AI. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit www.bruker.com.

The DISQVER® platform provides advanced bioinformatics and reporting to support rapid and comprehensive WGS analysis directly from cell-free human blood samples

The DISQVER® platform provides advanced bioinformatics and reporting to support rapid and comprehensive WGS analysis directly from cell-free human blood samples

President Donald Trump says Immigration and Customs Enforcementshould continue traffic stops after two deadly shootings within a week, seeming to contradict a new policy to halt them. To remove criminals from the country, “we CANNOT give up one of ICE’s most important and effective Crime Fighting tools, THE TRAFFIC STOP!” the president wrote on social media.

In Florida on Tuesday, a third man in roughly a week died during an encounter with immigration officers. The 28-year-old was killed after he was hit by a tractor-trailer while running from immigration and other federal officers, authorities said.

Here's the latest:

Photos showed bullet holes in Johan Sebastián Durán Guerrero’s car windshield, but the officers involved in the shooting didn’t have body cameras, leaving many questions. Among them are how close the officer was to the vehicle when shooting, whether officers told Durán Guerrero to stop and why ICE believes he had put the public in danger.

Border czar Tom Homan told reporters Tuesday the investigation needs to play out and that officers will be held accountable if they’re found to have acted inappropriately or illegally.

Maine’s attorney general’s office, which said it is working with federal agencies to investigate, said initial statements suggest the driver was trying to flee in the direction of the officer, whose name hasn’t been released and who was placed on leave.

Hundreds of people in Maine protested Tuesday over the fatal shooting of Johan Sebastián Durán Guerrero, a 25-year-old Colombian national. Advocacy groups said Guerrero, who had a wife and a young daughter, was authorized to work in the United States.

DHS said Monday that an officer, “fearing for public safety,” shot and killed Durán Guerrero while officers were watching the home of someone they believed was in the U.S. illegally and facing a final order of removal from the country. It said in a post on X that when ICE tried to stop a car driven by someone who came from the home, the person attempted to flee in the vehicle and the officer fired.

In a scathing post on X, outgoing Colombian President Gustavo Petro called the shooting a targeted killing “at the hands of the U.S. government.”

As the committee convened Wednesday for a confirmation hearing, the late South Carolina Republican’s seat at the rostrum was also marked with a vase of white roses.

Graham had been set to chair the panel in the next Congress. He died over the weekend of a tear in his aorta.

On Tuesday, Graham’s sister, Darline Graham, was sworn in to serve out the remaining months of his term, which expires in January. South Carolina Republicans are standing up a special primary election to pick a new nominee for this fall’s midterms.

Acting Attorney General Todd Blanche is expected to face bipartisan scrutiny as he seeks the chance to serve out the duration of Trump’s term.

Blanche, Trump’s former personal attorney, has run the department on an interim basis since April, when Pam Bondi was fired after struggling to bring successful cases against Trump’s political foes.

Since taking the reins at the Justice Department, Blanche has accelerated investigations into Trump foes, functioned as the public face of a maligned fund meant to compensate the president’s allies and alarmed press freedom advocates with an aggressive pursuit of news media leaks.

Jay Clayton, President Trump’s pick to head the nation’s intelligence agencies, will testify before the Senate Intelligence Committee on Wednesday, weeks after Trump abruptly delayed his nomination.

Republicans and even some Democrats have been eager to quickly confirm Clayton, the U.S. attorney for the Southern District of New York and a former Securities and Exchange Commission chairman, as they’ve expressed concerns about Trump’s interim appointee for the intelligence post, Bill Pulte. Pulte, who has been in the job since June 19, is a former housing official with no known intelligence experience and who used his previous administration perch to target perceived adversaries of the president.

Senate Intelligence Committee Chairman Tom Cotton, a Republican, expressed frustration when Trump delayed Clayton’s nomination in a social media post last month, allowing Pulte to take office. Cotton said then that Clayton had been instructed not to appear at a scheduled confirmation hearing, but he rescheduled the hearing three weeks later, with apparent approval from the White House.

▶ Read more

Acting Attorney General Todd Blanche will confront questions Wednesday about his brief but turbulent tenure atop the Justice Department during a Senate confirmation hearing that will test President Donald Trump’s grip on Republican lawmakers whose support the nominee will need for the job.

Blanche, Trump’s former personal attorney, has run the department on an interim basis since April, during which time he’s accelerated investigations into Trump foes, functioned as the public face of a maligned fund meant to compensate the Republican president’s allies and alarmed press freedom advocates with an aggressive pursuit of news media leaks.

Those actions will receive fresh scrutiny at a Senate Judiciary Committee hearing as Blanche testifies for the opportunity to serve out the duration of Trump’s term.

▶ Read more

President Donald Trump speaks as he meets with Iraq's Prime Minister Ali al-Zaidi in the Oval Office of the White House, Tuesday, July 14, 2026, in Washington. (AP Photo/Julia Demaree Nikhinson)

President Donald Trump speaks as he meets with Iraq's Prime Minister Ali al-Zaidi in the Oval Office of the White House, Tuesday, July 14, 2026, in Washington. (AP Photo/Julia Demaree Nikhinson)

President Donald Trump speaks as he meets with Iraq's Prime Minister Ali al-Zaidi in the Oval Office of the White House, Tuesday, July 14, 2026, in Washington. (AP Photo/Julia Demaree Nikhinson)

President Donald Trump speaks as he meets with Iraq's Prime Minister Ali al-Zaidi in the Oval Office of the White House, Tuesday, July 14, 2026, in Washington. (AP Photo/Julia Demaree Nikhinson)

Recommended Articles